Involvement inventing the breast cancer drug Herceptin and discussed the investment offering for his latest therapeutic development company|H. Michael Shepard , CEO OF ENOSI THERAPEUTICS 00:10:00
H. Michael Shepard, whose research in humanized antibodies created the first monoclonal antibody therapy targeting cancer oncogene encoded-proteins